Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsSelectHealth Drug Prior Auth Policy Update | OpenP…
    Ask Trek AI about this page
    CurrentSelectHealthPolicy N/A

    Prior Authorization Request Form — Drug Benefit (including SUD medications)

    Customize your policy alerts

    Sign up for all SelectHealth policy alerts

    Know when SelectHealth releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This document is a SelectHealth prior authorization request form for prescription drug benefits, including requests for medications to treat substance use disorders; it governs submission requirements for providers and pharmacies seeking prior authorization or reauthorization.

    Policy Summary
    PayerSelectHealth
    PolicyPrior Authorization Request Form — Drug Benefit (including SUD medications)
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateN/A
    Next Review DateN/A
    Key ActionSubmit a completed prior authorization form with patient and prescriber details, diagnosis (ICD code), drug information (with J‑Code if applicable), treatment location, prior medication history, and prescriber signature.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    1form type
    2020-01-01SUD prior auth reference
    800-538-5038contact phone

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    801-650-3279fax

    Coverage criteria & SUD prior-auth guidance

    Authorization and approval criteria

    Form submission and approval elements

    Form completion requirements: Submit completed form with patient and prescriber identifiers, diagnosis and ICD code(s), drug(s) requested (with J-Code if applicable), strength/route/frequency, quantity/volume, start date and length of therapy, location of treatment (including name, Type 2 NPI if applicable, address and tax ID), clinical criteria including other medications tried with duration and patient response, and prescriber signature.

    Supported by form fields in document

    Request type: Request may be New Request or Reauthorization as indicated on the form.

    Form checkboxes for New Request/Reauthorization

    SUD medication prior authorization exception: As of January 1, 2020, no prior authorization requirements may be imposed by a carrier for any FDA‑approved prescription medication on its formulary which is approved to treat substance use disorders.

    Legal/coverage note included on form

    No prior authorization may be imposed for FDA‑approved prescription medications on the carrier’s formulary that are approved to treat substance use disorders. This legal requirement has been in effect since January 1, 2020 and supersedes any prior authorization requirement that would otherwise apply to such formulary SUD medications.

    When completing a drug prior authorization request for a medication used to treat a substance use disorder, providers should note whether the drug is being prescribed for SUD on the form. If the drug is an FDA‑approved SUD medication and it appears on the carrier’s formulary, the carrier may not require prior authorization under this policy statement; for all other medications and indications, follow the standard prior authorization submission and documentation requirements on the form.

    Requested drug codes

    Requested drug J-CodesHCPCS
    J-Code if applicableJ-Code for administered drugs (document requests inclusion if applicable)

    Provider submission requirements and important notes

    Prior Authorization

    Prior Authorization Required

    Prior authorization is required for new requests and reauthorizations unless the medication is an FDA‑approved SUD treatment listed on the carrier's formulary (per state rule effective Jan 1, 2020). Complete and submit the prior authorization form with all required details to support approval.

    • Submit completed prior authorization form including patient and prescriber information, diagnosis ICD‑10 code(s), drug name(s) and J‑codes (if applicable), strength/route/frequency, quantity/volume, start date and length of therapy, location of treatment (with Type 2 NPI and tax ID when applicable), dispensing pharmacy name and phone number, prescriber signature and date.
    • Provide clinical criteria for approval: clinical rationale, other pertinent information, and a complete medication history — list other medications tried, their names, durations, and the patient’s response to each to support step‑therapy or failure documentation.
    • Indicate whether this is a New Request or Reauthorization.
    • If the drug is being prescribed to treat a substance use disorder, note this on the form; do not apply PA requirements to FDA‑approved SUD medications on the formulary per the SUD PA prohibition.
    • If the request is urgent, mark the form accordingly and include justification that waiting could seriously jeopardize life or health.

    New request (Initial authorization) criteria

    Initial authorization

    New Request

    New prior authorization submission: For new requests, provide diagnosis and ICD code(s); drug name, strength, route, frequency, quantity/volume; start date and length of therapy; prior medication history (other medications tried, duration, and patient response); location of treatment details; and prescriber signature, then submit the completed form.

    Form fields captured in document

    Reauthorization / continuation criteria

    Reauthorization

    Reauthorization

    Reauthorization submission: For reauthorization, submit current therapy details including start date, length of therapy, quantity, number of refills, and clinical response as requested on the form, and sign and submit the form.

    Form includes checkbox for Reauthorization

    Prior medication history / step therapy documentation

    MedicationDurationPatient response
    [form field] Other medications tried (list names)[form field] Duration of each medication tried[form field] Patient response to each medication (e.g., improved, no response, intolerable side effects)

    Treatment location information

    Billing Rule

    Provide location of treatment and identifiers

    Specify the site of care on the form (for example: provider office, facility, or home health) and include the site name, Type 2 NPI if applicable, full address, and contact information.

    • Site name
    • Type 2 NPI (if applicable)
    • Full address
    • Contact phone/fax
    Policy Summary
    PayerSelectHealth
    PolicyPrior Authorization Request Form — Drug Benefit (including SUD medications)
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateN/A
    Next Review DateN/A
    Key ActionSubmit a completed prior authorization form with patient and prescriber details, diagnosis (ICD code), drug information (with J‑Code if applicable), treatment location, prior medication history, and prescriber signature.
    SourceLink
    On This Page
    Coverage criteria & SUD prior-auth guidanceRequested drug codesProvider submission requirements and important notesNew request (Initial authorization) criteriaReauthorization / continuation criteriaPrior medication history / step therapy documentationTreatment location information
    Denial Risk

    Denial follow‑up — provide reason and alternatives

    When a prior authorization decision results in denial, the form requests the reason for denial and requests that the reviewer include alternative formulary medications when applicable. Use this information to determine next steps (appeal, select alternative therapy, or resubmit with additional documentation).

    • If denied, document the reason for denial on the form.
    • If denied, list alternative formulary medications suggested by the reviewer, if any, to guide subsequent prescribing or appeals.
    Documentation Required

    Submission checklist

    Checklist — ensure the submission includes all items requested on the form to avoid delays or denials.

    • Patient and prescriber identifying information (name, DOB, member/subscriber number, contact details, prescriber NPI/DEA/Tax ID).
    • Diagnosis and ICD‑10 code(s).
    • Drug name (brand and scientific), strength, route, frequency, quantity, number of refills, and J‑code if applicable.
    • Start date and length of therapy, location of treatment and facility identifiers when applicable.
    • Complete medication history: other medications tried, duration of therapy for each, and patient response.
    • Supporting clinical documentation and prescriber signature/date.